Ceres (NASDAQ: CERE) announced favorable results from its biotech corn evaluations in China, where a second year of field trials ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE